speb/financial-data huggingface dataset:
Financial scorecard for LAXMIDENTL.NS (Healthcare — Medical Instruments & Supplies, India)
Report date: 2026-03-31 (annual)
Stock price: 2.234104046242775
Market cap: 11896007680 (USD: 126070450.1907588)
P/E ratio: 0.31742510372228827
P/B ratio: 3.5472314215690064
Debt to equity: 0.0533
Current ratio: 6.13
Interest coverage ratio: 20.150073206442165
Return on net tangible assets (%): 12.048539318348563
Buffett classification: The Good
Analyst consensus upside (%): 19265.066287519745
Rule of 40 score: -6.502530586968101
Altman Z-score: 15.307876361453449 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 4.199417054606236, earnings yield % 0.008165557834708403, rank 2567
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -5.387308956001198, 3m 11.108984723303685, 6m -1.5144119046757367, 12m -58.02857369093808, composite -15.348040069592102 (Strong Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 6, short score 2, recommendation: Neutral
Revenue growth 1y (%): 8.299052860481781
Net income growth 1y (%): 113.69676667355031
Revenue deceleration: no
Beneish M-score: -0.8694247047919998 (Strong Manipulation Signal)
ROE (%): 4.1349872189814505
Net margin (%): 13.98448323635356
Asset turnover: 0.24553358823289295
Equity multiplier (leverage): 1.2042505079635577
ROE archetype: Low Return
P/E z-score: 2.745143111354124
Treasury beta 1y: 0.0012057817320679442 (R-squared: 9.075927795470427e-05)
Insider 90-day net shares: 55179 (net value USD: 109211.00)
ROIC (%): 16.429568845372746 (pretax: 17.981146743142343)
Incremental ROIC 3y (%): 28.346120277837528 (pretax: 30.98364602123737)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 14.11042944785276, P/B 54.601226993865026, ROIC 17.791411042944784, revenue growth 1y 31.901840490797547, 6m momentum 36.809815950920246
Sector percentiles: P/E 8.488538681948423, 6m momentum 31.088825214899714
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10189930976749152
Base cash flow: 3063056.3798219585
DCF price per share: base 0.014729735561265106, conservative 0.009049679924260118, aggressive 0.024817780773962593
Financial scorecard for LOOP (Basic Materials — Specialty Chemicals, Canada)
Report date: 2026-05-31 (quarterly)
Stock price: 0.79
Market cap: 38868228 (USD: 38868228)
Debt to equity: -0.25070727242469626
Current ratio: 0.68
Interest coverage ratio: -59.54545454545455
Buffett classification: The Gruesome
Analyst consensus upside (%): 227.33812949640287
Rule of 40 score: -1252.105069703594
Altman Z-score: -43.107744018342764 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.08231693459231332
Total shareholder yield (%): 0.08231693459231332 (Low Return)
Momentum (%): 1m 0, 3m -40.15151515151515, 6m -32.47863247863248, 12m -37.3015873015873, composite -36.64391164391164 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -28.968253968253965
Revenue deceleration: no
Revenue growth consistency score: 1424.302950126522
Accrual ratio: -0.27681210296205727
FCF conversion rate: 0.3734121122599705
Beneish M-score: inf (Strong Manipulation Signal)
Net margin (%): -1891.0614525139663
Asset turnover: 0.02336132316370026
ROE archetype: Standard Business
Treasury beta 1y: 0.005778598612271675 (R-squared: 0.00092192421963599)
Insider 90-day net shares: 50000 (net value USD: 66070.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 58.139534883720934, 6m momentum 80.23255813953489
Sector percentiles: P/E , 6m momentum 57.30149916712938
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12471114324765074
Base cash flow: -8851094.890510948
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MBX (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 62
Market cap: 2951047168 (USD: 2951047168)
P/B ratio: 3.2456127376894894
Debt to equity: 0.0013
Current ratio: 30.79
Return on net tangible assets (%): -5.457378082767569
Buffett classification: The Gruesome
Analyst consensus upside (%): 157.95644891122276
Rule of 40 score: 0
Altman Z-score: 118.66096497360053 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0013893373323404636
Total shareholder yield (%): 0.0013893373323404636 (Low Return)
Momentum (%): 1m 28.099173553719016, 3m 93.99249061326658, 6m 63.80449141347423, 12m 375.82501918649274, composite 143.08249362518376 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.006855683330448949
FCF conversion rate: 0.8778755793681167
Beneish M-score: -2.3665807160308048 (Likely Safe)
ROE (%): -5.828404456621548
Asset turnover: 0
Equity multiplier (leverage): 1.0382488267972276
ROE archetype: Low Return
Treasury beta 1y: -0.008653496296231064 (R-squared: 0.0007822913305006381)
Insider 90-day net shares: -52341 (net value USD: -2184607.00)
Incremental ROIC 3y (%): -71.34164199259159 (pretax: -90.30587593998935)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 35.37906137184115, ROIC , revenue growth 1y , 6m momentum 5.6859205776173285
Sector percentiles: P/E , 6m momentum 4.226361031518625
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10188053484471273
Base cash flow: -88652000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MHM.AX (Basic Materials — Other Precious Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.08333333333333333
Market cap: 5688000 (USD: 3717647.058823529)
Current ratio: 29.66
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 0 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -16.66666666666669, 6m -44.696969696969695, 12m -25.980392156862752, composite -29.284836191529916 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.0025104485654407114 (R-squared: 0.00013533312481535007)
Insider 90-day net shares: 30303 (net value USD: 3269.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 53.29512893982808
Sector percentiles: P/E , 6m momentum 67.29594669627984
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MMTX (Financial Services — Shell Companies, Taiwan)
Report date: 2026-03-31 (quarterly)
Stock price: 10.1
Market cap: 89163816 (USD: 89163816)
P/E ratio: 3602.6307459552495
P/B ratio: 40.479571475389704
Debt to equity: 0
Current ratio: 14.82
Return on net tangible assets (%): 0.6611704497067639
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 2319.2017710434925 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -0.19762845849801955, 3m 0.49751243781093457, 6m 1.405622489959827, 12m , composite 0.9515674638853808 (Flat)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.009586558030543847
FCF conversion rate: -0.465258391591002
Beneish M-score: -2.4756696719362727 (Likely Safe)
ROE (%): 0.6611704497067639
Asset turnover: 0
Equity multiplier (leverage): 1.010566614856107
ROE archetype: Low Return
Treasury beta 1y: -5.6361263140934476e-05 (R-squared: 0.0004884835509479985)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 27.333333333333332, P/B 29.733333333333334, ROIC , revenue growth 1y , 6m momentum 13.333333333333334
Sector percentiles: P/E 59.958613554061046, 6m momentum 36.44593895499224
Industry median P/E: 51.21654844258756; industry median ROIC: -0.6045051234646484
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.1019
Base cash flow: 0
DCF price per share: base 8.03191882194348e-05, conservative 8.03191882194348e-05, aggressive 8.03191882194348e-05
Financial scorecard for MNDY (Technology — Software - Application, Israel)
Report date: 2026-03-31 (quarterly)
Stock price: 77.43
Market cap: 3273285120 (USD: 3273285120)
P/E ratio: 30.17903930131004
P/B ratio: 12.168515760071493
Debt to equity: 0.2341
Current ratio: 1.72
Return on net tangible assets (%): 3.8797086033708053
Buffett classification: The Great
Analyst consensus upside (%): 57.053971928809155
Rule of 40 score: 26.505463104828955
Altman Z-score: 6.959654664842744 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 2.535056908524151, earnings yield % 0.23296644669987188, rank 2400
Dividend yield (%): 0
Buyback yield (%): 5.342559807007383
Debt paydown yield (%): -0.09539662997561933
Total shareholder yield (%): 5.247163177031764 (Moderate Return)
Momentum (%): 1m 9.179357021996623, 3m 14.220386487682548, 6m -40.12527064645839, 12m -73.23262004355792, composite -33.79599894056197 (Strong Downtrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 8, short score 4, recommendation: Neutral
Revenue growth 1y (%): 45.32495991748044
Net income growth 1y (%): 19.36519621984005
Revenue deceleration: no
Accrual ratio: -0.038949162527154454
FCF conversion rate: 3.6297353213954486
Beneish M-score: -2.6448880368463428 (Likely Safe)
ROE (%): 2.806648324746493
Net margin (%): 7.9808691443781745
Asset turnover: 0.18558201859825985
Equity multiplier (leverage): 1.8949681470495114
ROE archetype: Low Return
P/E z-score: 2.399441093867834
FCF z-score: 3.7944190062732166
Treasury beta 1y: 0.0257620384200252 (R-squared: 0.02790573548241725)
Insider 90-day net shares: -2611 (net value USD: -223327.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 45.14824797843666, P/B 68.59838274932615, ROIC , revenue growth 1y 6.199460916442049, 6m momentum 77.088948787062
Sector percentiles: P/E 43.84384384384384, 6m momentum 72.67267267267268
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.1154824353348726
Base cash flow: 35278301.88679245
DCF price per share: base 10.648076883410125, conservative 7.736425555749797, aggressive 15.68286834587283
Financial scorecard for MNE.AX (Energy — Oil & Gas E&P, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.09722222222222224
Market cap: 19627770 (USD: 12828607.843137255)
Debt to equity: 0.0288
Current ratio: 0.75
Return on net tangible assets (%): -8.877488389816598
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -11.892361111111107, 3m -28.3625730994152, 6m , 12m , composite -28.3625730994152 ()
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: 53.397983969613094 (Strong Manipulation Signal)
ROE (%): -17.957889232374207
Equity multiplier (leverage): 1.0202694295401105
ROE archetype: Low Return
Treasury beta 1y: 0.015442217109575994 (R-squared: 0.008736188503836353)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -14.924700925768017 (pretax: -18.89202648831394)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 59.23423423423423, revenue growth 1y , 6m momentum 
Industry median P/E: 11.260253542132737; industry median ROIC: 0.8337488598897688
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.1019
Base cash flow: -888332.0261437908
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MPTI (Technology — Electronic Components, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 81.9
Market cap: 361186208 (USD: 361186208)
P/E ratio: 25.22641509433962
P/B ratio: 3.9546134146007583
Debt to equity: 0.0018
Current ratio: 11.76
Return on net tangible assets (%): 3.0652915314130746
Buffett classification: The Great
Analyst consensus upside (%): 25.654450261780116
Rule of 40 score: 11.925764890367285
Altman Z-score: 36.38854426659278 (Safe Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 3.591232439423752, earnings yield % 0.8438130823021528, rank 1712
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.005537309996067181
Total shareholder yield (%): 0.005537309996067181 (Low Return)
Momentum (%): 1m -9.111086449894566, 3m 29.179810725552063, 6m 32.01160541586074, 12m 94.86081370449679, composite 58.52863209155032 (Strong Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 6, short score 5, recommendation: Neutral
Revenue growth 1y (%): 15.34715677034244
Net income growth 1y (%): 46.50306748466257
Revenue deceleration: no
Accrual ratio: 0.009778030580045775
FCF conversion rate: 0.6976549413735343
Beneish M-score: -3.1568428540794686 (Likely Safe)
ROE (%): 3.5049095152128924
Net margin (%): 16.260384039221027
Asset turnover: 0.1988921843470253
Equity multiplier (leverage): 1.083747963541896
ROE archetype: Low Return
P/E z-score: 4.0813120584948965
FCF z-score: 4.08131205849489
Treasury beta 1y: 0.000767819783879721 (R-squared: 3.788563849211726e-05)
Insider 90-day net shares: -2947 (net value USD: -194864.00)
ROIC (%): 18.68463521643773 (pretax: 24.230080994537577)
Incremental ROIC 3y (%): 20.509072894520155 (pretax: 25.58917911735275)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 57.80590717299579, P/B 59.07172995780591, ROIC 13.924050632911392, revenue growth 1y 17.72151898734177, 6m momentum 23.628691983122362
Sector percentiles: P/E 42.54254254254254, 6m momentum 14.347681014347682
Industry median P/E: 0.3075109007312397; industry median ROIC: 6.761415373399656
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08537825604350958
Base cash flow: 6982000
DCF price per share: base 76.22075876688201, conservative 44.508064579841545, aggressive 134.04413819544934
Financial scorecard for MUN.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.2553191489361702
Market cap: 40369752 (USD: 29042987.050359715)
P/B ratio: 13.963178583425517
Debt to equity: 0
Current ratio: 1.23
Return on net tangible assets (%): -2.3735884585768146
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -5.1999794377371655 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 13.29787234042552, 3m -18.65413161801088, 6m -14.063310845874419, 12m 44.68085106382979, composite -1.6726373158177854 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Net income growth 1y (%): -25752.588173363743
Revenue deceleration: no
Accrual ratio: -0.14559970218794316
FCF conversion rate: -10.92564269009488
Beneish M-score: -3.5660952578585703 (Likely Safe)
ROE (%): -3.1343465275253015
Asset turnover: 0
Equity multiplier (leverage): 2.5672509072825345
ROE archetype: Low Return
Treasury beta 1y: 0.010397899610377164 (R-squared: 0.0030148362424039436)
Insider 90-day net shares: -241381 (net value USD: -62121.00)
Incremental ROIC 3y (%): -560.3449375021498 (pretax: -709.2973892432277)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 55.037468776019985, ROIC , revenue growth 1y , 6m momentum 29.142381348875933
Sector percentiles: P/E , 6m momentum 38.284286507495835
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06230000000000001
Base cash flow: -1102345.2554744524
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NAMM (Basic Materials — Gold, Cayman Islands)
Report date: 2025-12-31 (annual)
Stock price: 1.52
Market cap: 82813640 (USD: 82813640)
P/E ratio: 0.5489130434782609
Debt to equity: -0.13196690006365372
Current ratio: 0.3
Interest coverage ratio: 6.30327868852459
Return on net tangible assets (%): -244.66709102482494
Buffett classification: The Gruesome
Analyst consensus upside (%): 840.5940594059406
Rule of 40 score: -2.373261318988528
Altman Z-score: 3.3050790077424597 (Safe Zone)
Piotroski F-score: 2 (Weak)
Magic formula: return on capital % 134.8088090281582, earnings yield % 14.288760236368425, rank 37
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.997255524573005
Total shareholder yield (%): -1.997255524573005 (Minimal or Negative)
Momentum (%): 1m -12.13872832369942, 3m -25.85365853658536, 6m -50.967741935483865, 12m -76.61538461538461, composite -50.06867195222821 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 9, short score 4, recommendation: Long
Revenue growth 1y (%): -3.82734449593628
Net income growth 1y (%): 2719.9554069119285
Revenue CAGR 3y (%): 20.113215776745985
Net income CAGR 3y (%): 225.717581096328
FCF CAGR 3y (%): -22.78980965123075
Revenue deceleration: yes
Revenue growth consistency score: 22.100516487187203
Beneish M-score: -2.2993617324681037 (Likely Safe)
ROE archetype: Standard Business
P/E z-score: 2.0033041141057253
FCF z-score: 2.003304114105724
Treasury beta 1y: 0.004223044665334051 (R-squared: 8.364293130044855e-05)
Insider 90-day net shares: -100 (net value USD: -1250.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 2.8328611898017, P/B , ROIC , revenue growth 1y 16.855524079320112, 6m momentum 70.6798866855524
Sector percentiles: P/E 15.796779566907274, 6m momentum 72.57079400333149
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06171672847761805
Base cash flow: 96093000
DCF price per share: base 91.34814735650806, conservative 46.83879360566684, aggressive 179.92672244068874
Financial scorecard for NDA.V (Financial Services — Capital Markets, Canada)
Report date: 2026-02-28 (quarterly)
Stock price: 0.3617021276595745
Market cap: 65423356 (USD: 47754274.45255474)
P/E ratio: 11.45161373167247
P/B ratio: 1.8759641805948128
Debt to equity: 0.0151
Current ratio: 1.59
Interest coverage ratio: -5.00132399078897
Return on net tangible assets (%): 18.283476202645733
Buffett classification: The Gruesome
Rule of 40 score: -453.6193718682969
Altman Z-score: 1.4943604390407919 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.0759053867988198
Total shareholder yield (%): -2.0759053867988198 (Minimal or Negative)
Momentum (%): 1m -18.47348868625464, 3m -49.946271222866955, 6m -50.57931325047398, 12m -64.86322188449847, composite -52.47566430801505 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 3, short score 7, recommendation: Neutral
Revenue growth 1y (%): -55.01345379109386
Revenue deceleration: no
Accrual ratio: 0.04500021426964851
FCF conversion rate: -0.47581347874940816
Beneish M-score: -3.1164508898826875 (Likely Safe)
ROE (%): 3.8341902556240703
Net margin (%): 878.1543335817462
Asset turnover: 0.0034722601839291163
Equity multiplier (leverage): 1.257449492447459
ROE archetype: Low Return
P/E z-score: 2.2096997809890055
Treasury beta 1y: 0.010540165709979224 (R-squared: 0.001953207541601214)
Insider 90-day net shares: 33350 (net value USD: 14906.00)
ROIC (%): -2.643417563527183 (pretax: -4.066796251580281)
Incremental ROIC 3y (%): 4.21239494051493 (pretax: 4.150115318110979)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 42.857142857142854, P/B 48.35164835164835, ROIC 39.83516483516483, revenue growth 1y 54.670329670329664, 6m momentum 75.54945054945054
Sector percentiles: P/E 35.359544749094674, 6m momentum 67.95137092602172
Industry median P/E: 0.9254498714652956; industry median ROIC: 1.51204420306575
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.15
Base cash flow: 402962.7737226277
DCF price per share: base 0.02950821509090524, conservative 0.027730397219415254, aggressive 0.03148895968538212
Financial scorecard for NECCLTD.NS (Industrials — Trucking, India)
Report date: 2026-03-31 (annual)
Stock price: 0.157411230388109
Market cap: 1593624960 (USD: 16888776.600254346)
P/E ratio: 0.14568149723245732
P/B ratio: 0.4936186071649228
Debt to equity: 0.5478999999999999
Current ratio: 2.61
Interest coverage ratio: 1.469255976363148
Return on net tangible assets (%): -0.528823810635624
Buffett classification: The Gruesome
Rule of 40 score: -22.931725243459532
Altman Z-score: 2.27742423394748 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -5.00768143159162
Total shareholder yield (%): -5.00768143159162 (Minimal or Negative)
Momentum (%): 1m -9.3075005548413, 3m -6.121857466255148, 6m -9.0115387983885, 12m -40.13939126085995, composite -16.376490632983202 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue growth 1y (%): -15.050378499912021
Net income growth 1y (%): -31.468148826695664
Revenue CAGR 3y (%): -4.320452294237365
Net income CAGR 3y (%): 5.329096605178729
Revenue deceleration: yes
Revenue growth consistency score: 12.539640958268071
Accrual ratio: 0.018932725845160623
FCF conversion rate: -9.235966290529925
Beneish M-score: -1.6172429225759681 (Possible Manipulation)
ROE (%): 0.3012584203330949
Net margin (%): 0.7275293100474073
Asset turnover: 0.25423410196961255
Equity multiplier (leverage): 1.6287517500054378
ROE archetype: Low Return
P/E z-score: 4.908323550865067
Treasury beta 1y: 0.000981546954907854 (R-squared: 8.232099590413254e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 2.907074549324582 (pretax: 4.001086063829072)
Incremental ROIC 3y (%): -3.153797082050384 (pretax: -6.568789146647967)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 20.51282051282051, P/B 7.6923076923076925, ROIC 46.15384615384615, revenue growth 1y 66.66666666666666, 6m momentum 69.23076923076923
Sector percentiles: P/E 23.015873015873016, 6m momentum 55.19713261648745
Industry median P/E: 6.559885845838838; industry median ROIC: 3.062543534284001
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.06659889231741688
Base cash flow: -126017.38024586672
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NGX.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.0625
Market cap: 7973842 (USD: 5211661.437908497)
Current ratio: 11.19
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444459, 3m -2.7777777777777892, 6m -29.807692307692314, 12m -32.589285714285715, composite -21.87988575919611 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.002323867921293465 (R-squared: 0.00010027394981009752)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 42.298084929225645
Sector percentiles: P/E , 6m momentum 53.9422543031649
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NHU.AX (Energy — Uranium, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.0625
Market cap: 14556967 (USD: 9514357.516339868)
Current ratio: 1.86
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.3606520506641253
Total shareholder yield (%): 0.3606520506641253 (Low Return)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 5, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.04306038788797462 (R-squared: 0.0005375489657067194)
Insider 90-day net shares: 880000 (net value USD: 78096.00)
Capital allocation category: Standard Allocator
Industry median P/E: 18.936598557423494; industry median ROIC: -13.899740371778044
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.1019
Base cash flow: -416866.0130718954
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NKLR (Utilities — Utilities - Regulated Electric, Italy)
Report date: 2026-03-31 (quarterly)
Stock price: 5.01
Market cap: 558029632 (USD: 558029632)
P/E ratio: 0.9606625258799171
Debt to equity: 0
Current ratio: 21.34
Buffett classification: The Gruesome
Analyst consensus upside (%): 262.0689655172414
Rule of 40 score: 0
Altman Z-score: -6.064635742890974 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 7.7419354838709555, 3m -30.991735537190085, 6m -17.462932454695228, 12m , composite -24.227333995942658 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.02775820864612821
FCF conversion rate: 0.5887981987053195
Beneish M-score: -2.622632139844775 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
P/E z-score: 1.8412875639165966
Treasury beta 1y: 0.0006490705894647667 (R-squared: 7.911297126963225e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 14.444444444444443, P/B , ROIC , revenue growth 1y , 6m momentum 92.22222222222223
Sector percentiles: P/E 19.153225806451612, 6m momentum 65.5241935483871
Industry median P/E: 17.96397344673207; industry median ROIC: 5.461095094053626
Sector median P/E: 8.380462724935732; sector median ROIC: 4.834251840514727
WACC: 0.1019
Base cash flow: 634618823.5294118
DCF price per share: base 115.23524778657726, conservative 83.58288258491982, aggressive 160.81015250475
Financial scorecard for NLH.V (Healthcare — Medical Care Facilities, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.2624113475177305
Market cap: 32306276 (USD: 23241925.179856118)
P/E ratio: 148.94825862543843
P/B ratio: 1.6012613605895785
Debt to equity: 0.14800000000000002
Current ratio: 1.02
Interest coverage ratio: 3.7146319065353803
Return on net tangible assets (%): 29.796675201474333
Buffett classification: The Great
Rule of 40 score: 0.4619033525349261
Altman Z-score: 4.790214317896772 (Safe Zone)
Piotroski F-score: 8 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.46445993351012194
Total shareholder yield (%): 0.46445993351012194 (Low Return)
Momentum (%): 1m -9.116069884103101, 3m -7.819603564284414, 6m 24.871606749816582, 12m 32.177567638560554, composite 20.82919320234136 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 10, short score 1, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 13.874766750713906
Revenue deceleration: no
Accrual ratio: -0.003030778892529668
FCF conversion rate: 1.2206465446860164
Beneish M-score: -2.488876782754183 (Likely Safe)
ROE (%): 1.6903394117746728
Net margin (%): 4.1338688474398655
Asset turnover: 0.332277113637168
Equity multiplier (leverage): 1.2305996701837076
ROE archetype: Low Return
FCF z-score: 4.518253797450369
Treasury beta 1y: 0.007530248706361522 (R-squared: 0.0015531052360751225)
Insider 90-day net shares: 168471 (net value USD: 50624.00)
ROIC (%): 4.2661763098909535 (pretax: 5.400223177077155)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 63.8095238095238, P/B 33.33333333333333, ROIC 48.095238095238095, revenue growth 1y 20.476190476190474, 6m momentum 14.285714285714285
Sector percentiles: P/E 33.77507163323782, 6m momentum 12.392550143266476
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12910254339907506
Base cash flow: 469463.50364963495
DCF price per share: base 0.044373118978123204, conservative 0.03737386074054438, aggressive 0.05268765126530144
Financial scorecard for NRC.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2025-12-31 (quarterly)
Stock price: 0.7021276595744681
Market cap: 153678336 (USD: 112173967.88321167)
P/B ratio: 36.9585899101317
Debt to equity: 0
Current ratio: 43.64
Return on net tangible assets (%): -10.078164148271568
Buffett classification: The Gruesome
Rule of 40 score: -132.6548063444112
Altman Z-score: 866.2979529681865 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 20.12304537298129, 3m -0.8335161219565552, 6m -45.25784349080419, 12m 70.51671732522794, composite -1.3798831170637815 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 94.32393805758312
Revenue deceleration: no
Accrual ratio: 0.04800352378869034
FCF conversion rate: 1.4927780697067512
Beneish M-score: -1.9500170273451907 (Likely Safe)
ROE (%): -10.001443398308567
Net margin (%): -84.47416962125888
Asset turnover: 0.11531818951085115
Equity multiplier (leverage): 1.0266937889382572
ROE archetype: Low Return
Treasury beta 1y: 0.00015035714195308551 (R-squared: 6.497110170118038e-07)
Insider 90-day net shares: 29500 (net value USD: 19602.00)
ROIC (%): -611.8096601099804 (pretax: -774.4426077341524)
Incremental ROIC 3y (%): -349.13034204246827 (pretax: -441.9371418259091)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 58.78434637801831, ROIC 57.368859283930064, revenue growth 1y 1.9983347210657785, 6m momentum 58.45129059117402
Sector percentiles: P/E , 6m momentum 67.62909494725152
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.0766
Base cash flow: -19963935.664335664
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NRDS (Communication Services — Internet Content & Information, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 8.88
Market cap: 584293184 (USD: 584293184)
P/E ratio: 11.161290322580646
P/B ratio: 1.053225162938727
Debt to equity: 0.0669
Current ratio: 2.57
Interest coverage ratio: 136
Return on net tangible assets (%): 16.77018633540373
Buffett classification: The Great
Analyst consensus upside (%): 15.606936416184963
Rule of 40 score: 9.606404296152775
Altman Z-score: 3.97385441537153 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 16.636085626911314, earnings yield % 4.941023938272776, rank 59
Dividend yield (%): 0
Buyback yield (%): 11.29569911258797
Total shareholder yield (%): 11.29569911258797 (High Return)
Momentum (%): 1m 3.0162412993039625, 3m -18.382352941176467, 6m -30.51643192488262, 12m -18.45730027548209, composite -23.247865539987256 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 9, short score 3, recommendation: Neutral
Revenue growth 1y (%): 6.214149139579339
Net income growth 1y (%): 10100
Revenue deceleration: no
Accrual ratio: -0.024857238831037957
FCF conversion rate: 1.5441176470588236
Beneish M-score: -2.7039505678777704 (Likely Safe)
ROE (%): 5.740818910932883
Net margin (%): 9.18091809180918
Asset turnover: 0.497592654797895
Equity multiplier (leverage): 1.2566483748417054
ROE archetype: Standard Business
P/E z-score: 2.8974584575334625
FCF z-score: 3.7999083910250797
Treasury beta 1y: 0.0025770598950114747 (R-squared: 0.0005321487604062051)
Insider 90-day net shares: -3923720 (net value USD: -35725842.00)
ROIC (%): 16.12111193247821 (pretax: 22.57617728531856)
Incremental ROIC 3y (%): 277.215621975355 (pretax: 381.77339901477836)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 35.9504132231405, P/B 22.31404958677686, ROIC 26.446280991735538, revenue growth 1y 24.793388429752067, 6m momentum 62.8099173553719
Sector percentiles: P/E 36.94060211554109, 6m momentum 66.55817737998373
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.11187076915030451
Base cash flow: 93800000
DCF price per share: base 81.22054975236775, conservative 48.509275804989755, aggressive 137.47456191601154
Financial scorecard for NRIX (Healthcare — Biotechnology, United States)
Report date: 2026-05-31 (quarterly)
Stock price: 23.38
Market cap: 2426415616 (USD: 2426415616)
P/B ratio: 4.5778417495100925
Debt to equity: 0.1444
Current ratio: 6.34
Return on net tangible assets (%): -21.762325924490906
Buffett classification: The Gruesome
Analyst consensus upside (%): 85.81081081081079
Rule of 40 score: -1170.629766051995
Altman Z-score: 8.166707063852757 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.02110108411039834
Total shareholder yield (%): 0.02110108411039834 (Low Return)
Momentum (%): 1m 21.139896373056985, 3m 40.167865707434046, 6m 25.9698275862069, 12m 102.77536860364268, composite 44.50903740027986 (Strong Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): -79.47385146177592
Revenue deceleration: no
Revenue growth consistency score: 9.443072550622164
Accrual ratio: 0.015318306349057328
FCF conversion rate: 1.1002289607416094
Beneish M-score: -1.9203090781428775 (Likely Safe)
ROE (%): -20.267792466497646
Net margin (%): -990.1028419772199
Asset turnover: 0.015436086952810945
Equity multiplier (leverage): 1.326138627308946
ROE archetype: Low Return
Treasury beta 1y: -0.0011406834044867212 (R-squared: 6.352843922622588e-05)
Insider 90-day net shares: -89898 (net value USD: -1691686.00)
ROIC (%): -14692.45703125 (pretax: -18598.046875)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 43.682310469314075, ROIC 46.57039711191336, revenue growth 1y 26.985559566787003, 6m momentum 13.808664259927797
Sector percentiles: P/E , 6m momentum 11.926934097421203
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1431571417686277
Base cash flow: -259603000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NRSN (Healthcare — Biotechnology, Israel)
Report date: 2025-12-31 (annual)
Stock price: 0.6
Market cap: 21735698 (USD: 21735698)
Debt to equity: -0.10897435897435898
Current ratio: 0.31
Buffett classification: The Gruesome
Analyst consensus upside (%): 744.1558441558442
Rule of 40 score: 0
Altman Z-score: -86.6651678376584 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.15393625498870728
Total shareholder yield (%): -0.15393625498870728 (Minimal or Negative)
Momentum (%): 1m -21.052631578947373, 3m -20.000000000000004, 6m -37.5, 12m -70.44334975369458, composite -40.020525451559934 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.5532524276541757 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.021852945826764458 (R-squared: 0.011177739527956499)
Insider 90-day net shares: 500000 (net value USD: 400000.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 58.57400722021661
Sector percentiles: P/E , 6m momentum 63.57449856733525
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.13250409259480325
Base cash flow: -3495911.9496855345
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NRX.AX (Basic Materials — Copper, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 7771690 (USD: 5079535.947712419)
Current ratio: 1.65
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m 1.3888888888888886, 12m 4.861111111111119, composite 0.9163473818646265 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.005020554785822318 (R-squared: 2.7421817481744123e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 13.131313131313133
Sector percentiles: P/E , 6m momentum 20.960577456968352
Industry median P/E: 8.111238786291718; industry median ROIC: 1.4751649297193823
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.08925
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NRX.V (Healthcare — Biotechnology, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3475177304964539
Market cap: 45102468 (USD: 32447818.705035973)
P/B ratio: 28.045937702297707
Debt to equity: 0.034
Current ratio: 2.23
Interest coverage ratio: -117.13333333333333
Return on net tangible assets (%): -85.51448551448551
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 10.028983749019996 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.092182632524159
Total shareholder yield (%): 0.092182632524159 (Low Return)
Momentum (%): 1m -10.277240490006456, 3m -19.305204952518316, 6m -23.877068557919625, 12m -35.25697075682503, composite -23.674430741822608 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.14486379967076413
FCF conversion rate: 0.7010192525481314
Beneish M-score: -3.1848822296542636 (Likely Safe)
ROE (%): -73.57930526917627
Asset turnover: 0
Equity multiplier (leverage): 1.5185847490100908
ROE archetype: Low Return
Treasury beta 1y: 0.010628344999163791 (R-squared: 0.007028771790914512)
Insider 90-day net shares: -3500 (net value USD: -1744.00)
ROIC (%): -686.1497252747254 (pretax: -868.5439560439562)
Incremental ROIC 3y (%): -55.59210241590411 (pretax: -70.36974989354947)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 64.07942238267148, ROIC 39.53068592057762, revenue growth 1y , 6m momentum 46.75090252707581
Sector percentiles: P/E , 6m momentum 53.22349570200573
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06800600496440706
Base cash flow: -4564963.503649635
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NVCT (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 19.31
Market cap: 608758016 (USD: 608758016)
P/B ratio: 17.137297474683546
Debt to equity: 0
Current ratio: 2.27
Return on net tangible assets (%): -42.54571026722925
Buffett classification: The Gruesome
Analyst consensus upside (%): 311.38421733505817
Rule of 40 score: 0
Altman Z-score: 26.706232244541297 (Safe Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -21.119281045751638, 3m 116.96629213483143, 6m 124.79627473806751, 12m 149.80595084087966, composite 152.8169315190819 (Strong Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.016145131069746264
FCF conversion rate: 1.0761983471074381
Beneish M-score: -2.4499800175608644 (Likely Safe)
ROE (%): -37.079030429320014
Asset turnover: 0
Equity multiplier (leverage): 1.7499770171298992
ROE archetype: Low Return
Treasury beta 1y: -0.0059180928195287094 (R-squared: 0.0009592147813422933)
Insider 90-day net shares: 62500 (net value USD: 1166000.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 61.55234657039711, ROIC , revenue growth 1y , 6m momentum 1.895306859205776
Sector percentiles: P/E , 6m momentum 1.2177650429799427
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -26442000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NVO.AX (Basic Materials — Gold, Australia)
Report date: 2026-03-31 (quarterly)
Stock price: 0.041666666666666664
Market cap: 28515940 (USD: 19531465.75342466)
P/B ratio: 0.6380102916851421
Debt to equity: 0.0055000000000000005
Current ratio: 1.05
Interest coverage ratio: -10.064516129032258
Return on net tangible assets (%): -1.2241907809758825
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -8.25240697059513 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0589097105623059
Total shareholder yield (%): 0.0589097105623059 (Low Return)
Momentum (%): 1m 0.6944444444444402, 3m -16.66666666666669, 6m -67.98245614035088, 12m -42.803030303030305, composite -42.61553832334232 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.00470054695927534
FCF conversion rate: 0.5708029197080292
Beneish M-score: -2.6229270751569933 (Likely Safe)
ROE (%): -1.4102528762408972
Asset turnover: 0
Equity multiplier (leverage): 1.2876723117542468
ROE archetype: Low Return
Treasury beta 1y: 0.0025658321884522305 (R-squared: 0.00010830484231121707)
Insider 90-day net shares: 33697638 (net value USD: 138159.00)
ROIC (%): -46.543820282678226 (pretax: -58.916228205921804)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 5.6657223796034, ROIC 46.45892351274787, revenue growth 1y , 6m momentum 79.60339943342775
Sector percentiles: P/E , 6m momentum 81.45474736257636
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10103197662886242
Base cash flow: -14920134.22818792
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OABI (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.03
Market cap: 294294336 (USD: 294294336)
P/B ratio: 0.8665921012693892
Debt to equity: 0.07490000000000001
Current ratio: 4.8
Return on net tangible assets (%): -1.1083867934034193
Buffett classification: The Gruesome
Analyst consensus upside (%): 366.8789808917197
Rule of 40 score: 13.87239690861393
Altman Z-score: 5.03811340894414 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2256244578217095
Total shareholder yield (%): 0.2256244578217095 (Low Return)
Momentum (%): 1m -10.964912280701755, 3m 39.04109589041095, 6m 3.5714285714285636, 12m -4.245283018867939, composite 16.71989809105342 (Flat)
Lynch category: Speculative (confidence: Low)
Screener: long score 6, short score 7, recommendation: Neutral
Revenue growth 1y (%): 247.30380356283098
Revenue deceleration: no
Accrual ratio: -0.008833363607618355
FCF conversion rate: 0.6592707927857792
Beneish M-score: -1.792251817064135 (Likely Safe)
ROE (%): -2.9100973619572827
Net margin (%): -53.42066957787481
Asset turnover: 0.048529678890750196
Equity multiplier (leverage): 1.1225114363012652
ROE archetype: Low Return
Treasury beta 1y: -1.4670606262931446e-05 (R-squared: 1.06727720853425e-08)
Insider 90-day net shares: -33314 (net value USD: -49638.00)
ROIC (%): -23.35066599238866 (pretax: -29.557805053656526)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 9.386281588447654, ROIC 15.974729241877256, revenue growth 1y 2.256317689530686, 6m momentum 25.09025270758123
Sector percentiles: P/E , 6m momentum 24.606017191977077
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10713440784916393
Base cash flow: -43590000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OIL.AX (Technology — Scientific & Technical Instruments, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.11111111111111112
Market cap: 167068256 (USD: 109194938.5620915)
P/B ratio: 14.893571189056452
Debt to equity: 0.0681
Current ratio: 14.01
Interest coverage ratio: -362.8315655001548
Return on net tangible assets (%): -77.52979248796467
Buffett classification: The Gruesome
Rule of 40 score: -681.5753750763122
Altman Z-score: 22.4680089044569 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 34.259259259259274, 3m 41.414141414141405, 6m 80.24691358024694, 12m 52.52525252525254, composite 45.08869022278984 (Moderate Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -19.238566763253118
Revenue CAGR 3y (%): -3.789779348215583
Revenue deceleration: no
Revenue growth consistency score: 48.990960756285524
Accrual ratio: -0.0005170234546399582
FCF conversion rate: 0.9989147572731858
Beneish M-score: -2.663071242325983 (Likely Safe)
Equity multiplier (leverage): 1.368675290267886
ROE archetype: Standard Business
Treasury beta 1y: 0.002277434895862918 (R-squared: 8.420555749488605e-05)
Insider 90-day net shares: -3000000 (net value USD: -256200.00)
ROIC (%): -159.5348265239924 (pretax: -201.9428183848005)
Incremental ROIC 3y (%): -150.97470686371273 (pretax: -191.10722387811734)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 66.42335766423358, ROIC 67.15328467153284, revenue growth 1y 37.22627737226277, 6m momentum 2.9197080291970803
Sector percentiles: P/E , 6m momentum 5.405405405405405
Industry median P/E: 0.9334334334334333; industry median ROIC: 7.349148361525377
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.051083864666009365
Base cash flow: -3905531.3725490193
DCF price per share: base 0, conservative 0, aggressive 0